← Leaderboards
David Camerini
University Of Virginia Charlottesville
$4,768,532
Attributed
$5,002,032
Total exposure
12
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $525.3K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,759,032 · 11
CDC$243,000 · 1
By mechanism
R43$1,738,908 · 6
R21$1,680,613 · 4
R01$1,507,011 · 1
R29$75,500 · 1
Top collaborators
- Dr. Rashidul Haque2 shared
- William A Petri2 shared
Others in their field
Top investigators on “Human Immunodeficiency Virus 1”
- Constance Ann Benson · University Of California, San Diego$122,634,267
- Barton F Haynes · Duke University$106,892,200
- Michael David Hughes · Harvard University D/B/A Harvard School Of Public Health$103,430,446
- George R Seage · Abt Associates, Inc.$96,260,237
- Dennis R. Burton · Scripps Research Institute$73,539,073
- Rama Rao Amara · Emory University$62,827,078
Research focus
Human Immunodeficiency Virus 1Scid MouseT LymphocyteInfectionPolymerase Chain ReactionSerumTissue MosaicismVirus Infection MechanismHiv InfectionsBiological Signal TransductionRecombinant VirusHiv Envelope ProteinProteinsAntibodiesCytokine ReceptorsGenetic StrainThymusImmune ResponseImmunityAntigensFutureProtein FragmentProtein MicrochipsResponse
Grant awards (22)
Humoral Immunity to Enteric Viruses among Infants and Mothers in Bangladesh$80,850
R21 · FY2025 · AI · contact PI
Humoral Immunity to Enteric Viruses among Infants and Mothers in Bangladesh$269,400
R21 · FY2024 · AI · contact PI
Identification of Serodiagnostic Epitopes for SARS-CoV-2, endemic HCoV?s and influenza virus$243,000
R43 · FY2021 · IP · contact PI
Discovery of Yellow Fever Virus-Specific Epitopes for Development of an Accurate Serodiagnostic Assay$295,679
R43 · FY2019 · AI · contact PI
Discovery of Yellow Fever Virus-Specific Epitopes for Development of an Accurate Serodiagnostic Assay$299,564
R43 · FY2018 · AI · contact PI
Pan-HIV Incidence Assay Development$225,707
R43 · FY2018 · AI · contact PI
Specific Detection of Antibodies to Emerging and Established Arboviruses Including Zika Virus$224,958
R43 · FY2017 · AI · contact PI
Point of Care Detection of Oral Pathogens$225,000
R43 · FY2015 · DE · contact PI
Development of a Pan-HIV Proteomic Chip$225,000
R43 · FY2014 · DE · contact PI
HIV Pathogenesis and Immunity in Viremic Non-Progressors$189,660
R21 · FY2011 · AI · contact PI
HIV Pathogenesis and Immunity in Viremic Non-Progressors$229,827
R21 · FY2010 · AI · contact PI
Defensin mediated inhibition of HIV-1 replication$228,750
R21 · FY2005 · AI
PATHOGENESIS OF R5 HIV-1 ISOLATES$314,122
R01 · FY2004 · AI
Defensin mediated inhibition of HIV-1 replication$227,626
R21 · FY2004 · AI
HIV-1 Clones with Attenuated Cytopathic Effects$227,250
R21 · FY2004 · AI
PATHOGENESIS OF R5 HIV-1 ISOLATES$315,047
R01 · FY2003 · AI
HIV-1 Clones with Attenuated Cytopathic Effects$227,250
R21 · FY2003 · AI
PATHOGENESIS OF R5 HIV-1 ISOLATES$284,652
R01 · FY2002 · AI
PATHOGENESIS OF R5 HIV-1 ISOLATES$29,850
R01 · FY2002 · AI
PATHOGENESIS OF R5 HIV-1 ISOLATES$256,740
R01 · FY2001 · AI
PATHOGENESIS OF R5 HIV-1 ISOLATES$306,600
R01 · FY2000 · AI
TESTING ANTIHIV-1 GENE THERAPY IN SCID-HU MICE$75,500
R29 · FY2000 · AI